The global market for Blood Test for Alzheimer's Disease was valued at US$ 53.55 million in the year 2024 and is projected to reach a revised size of US$ 116 million by 2031, growing at a CAGR of 13.6% during the forecast period.

Blood Test for Alzheimer's Disease Market

Blood Test for Alzheimer's Disease is a diagnostic method that measures specific biomarkers in the blood to detect pathological changes associated with the condition, such as abnormal protein accumulation or neurodegeneration indicators. It provides a less invasive and more accessible alternative to traditional diagnostic tools by identifying biochemical signals linked to early or progressive stages of the disease. This approach supports earlier clinical intervention, broader screening potential, and more streamlined patient management within healthcare systems.

North American market for Blood Test for Alzheimer's Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Blood Test for Alzheimer's Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Blood Test for Alzheimer's Disease in Early Diagnosis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Blood Test for Alzheimer's Disease include Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Fujirebio, Labcorp, Cognitact, Amoneta Diagnostics, MagQu, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Blood Test for Alzheimer's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Test for Alzheimer's Disease.

The Blood Test for Alzheimer's Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Test for Alzheimer's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, by Analytical Technology and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood Test for Alzheimer's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Blood Test for Alzheimer's Disease Market Report

Report Metric	Details
Report Name	Blood Test for Alzheimer's Disease Market
Accounted market size in year	US$ 53.55 million
Forecasted market size in 2031	US$ 116 million
CAGR	13.6%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Amyloid Beta (Aβ) Tau Proteins Others
Segment by Analytical Technology	Immunoassay-based Tests Mass Spectrometry-based Tests Others
Segment by Application	Early Diagnosis Clinical Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Fujirebio, Labcorp, Cognitact, Amoneta Diagnostics, MagQu, Diadem, Vazyme, KingMed Diagnostics, DIAN Diagnostics, Anqun Bioengineering
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Analytical Technology etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Test for Alzheimer's Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Blood Test for Alzheimer's Disease Market growing?

Ans: The Blood Test for Alzheimer's Disease Market witnessing a CAGR of 13.6% during the forecast period 2026-2031.

What is the Blood Test for Alzheimer's Disease Market size in 2031?

Ans: The Blood Test for Alzheimer's Disease Market size in 2031 will be US$ 116 million.

Who are the main players in the Blood Test for Alzheimer's Disease Market report?

Ans: The main players in the Blood Test for Alzheimer's Disease Market are Quanterix, C2N Diagnostics, Sysmex, Quest Diagnostics, Roche Diagnostics, Fujirebio, Labcorp, Cognitact, Amoneta Diagnostics, MagQu, Diadem, Vazyme, KingMed Diagnostics, DIAN Diagnostics, Anqun Bioengineering

What are the Application segmentation covered in the Blood Test for Alzheimer's Disease Market report?

Ans: The Applications covered in the Blood Test for Alzheimer's Disease Market report are Early Diagnosis, Clinical Research

What are the Type segmentation covered in the Blood Test for Alzheimer's Disease Market report?

Ans: The Types covered in the Blood Test for Alzheimer's Disease Market report are Amyloid Beta (Aβ), Tau Proteins, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood Test for Alzheimer's Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Amyloid Beta (Aβ)

1.2.3 Tau Proteins

1.2.4 Others

1.3 Market by Analytical Technology

1.3.1 Global Blood Test for Alzheimer's Disease Market Size Growth Rate by Analytical Technology: 2020 VS 2024 VS 2031

1.3.2 Immunoassay-based Tests

1.3.3 Mass Spectrometry-based Tests

1.3.4 Others

1.4 Market by Application

1.4.1 Global Blood Test for Alzheimer's Disease Market Growth by Application: 2020 VS 2024 VS 2031

1.4.2 Early Diagnosis

1.4.3 Clinical Research

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Blood Test for Alzheimer's Disease Market Perspective (2020-2031)

2.2 Global Blood Test for Alzheimer's Disease Growth Trends by Region

2.2.1 Global Blood Test for Alzheimer's Disease Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Blood Test for Alzheimer's Disease Historic Market Size by Region (2020-2025)

2.2.3 Blood Test for Alzheimer's Disease Forecasted Market Size by Region (2026-2031)

2.3 Blood Test for Alzheimer's Disease Market Dynamics

2.3.1 Blood Test for Alzheimer's Disease Industry Trends

2.3.2 Blood Test for Alzheimer's Disease Market Drivers

2.3.3 Blood Test for Alzheimer's Disease Market Challenges

2.3.4 Blood Test for Alzheimer's Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Blood Test for Alzheimer's Disease Players by Revenue

3.1.1 Global Top Blood Test for Alzheimer's Disease Players by Revenue (2020-2025)

3.1.2 Global Blood Test for Alzheimer's Disease Revenue Market Share by Players (2020-2025)

3.2 Global Top Blood Test for Alzheimer's Disease Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Blood Test for Alzheimer's Disease Revenue

3.4 Global Blood Test for Alzheimer's Disease Market Concentration Ratio

3.4.1 Global Blood Test for Alzheimer's Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood Test for Alzheimer's Disease Revenue in 2024

3.5 Global Key Players of Blood Test for Alzheimer's Disease Head office and Area Served

3.6 Global Key Players of Blood Test for Alzheimer's Disease, Product and Application

3.7 Global Key Players of Blood Test for Alzheimer's Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Blood Test for Alzheimer's Disease Breakdown Data by Type

4.1 Global Blood Test for Alzheimer's Disease Historic Market Size by Type (2020-2025)

4.2 Global Blood Test for Alzheimer's Disease Forecasted Market Size by Type (2026-2031)

5 Blood Test for Alzheimer's Disease Breakdown Data by Application

5.1 Global Blood Test for Alzheimer's Disease Historic Market Size by Application (2020-2025)

5.2 Global Blood Test for Alzheimer's Disease Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Blood Test for Alzheimer's Disease Market Size (2020-2031)

6.2 North America Blood Test for Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Blood Test for Alzheimer's Disease Market Size by Country (2020-2025)

6.4 North America Blood Test for Alzheimer's Disease Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Blood Test for Alzheimer's Disease Market Size (2020-2031)

7.2 Europe Blood Test for Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Blood Test for Alzheimer's Disease Market Size by Country (2020-2025)

7.4 Europe Blood Test for Alzheimer's Disease Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Blood Test for Alzheimer's Disease Market Size (2020-2031)

8.2 Asia-Pacific Blood Test for Alzheimer's Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Blood Test for Alzheimer's Disease Market Size by Region (2020-2025)

8.4 Asia-Pacific Blood Test for Alzheimer's Disease Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Blood Test for Alzheimer's Disease Market Size (2020-2031)

9.2 Latin America Blood Test for Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Blood Test for Alzheimer's Disease Market Size by Country (2020-2025)

9.4 Latin America Blood Test for Alzheimer's Disease Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Blood Test for Alzheimer's Disease Market Size (2020-2031)

10.2 Middle East & Africa Blood Test for Alzheimer's Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Blood Test for Alzheimer's Disease Market Size by Country (2020-2025)

10.4 Middle East & Africa Blood Test for Alzheimer's Disease Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Quanterix

11.1.1 Quanterix Company Details

11.1.2 Quanterix Business Overview

11.1.3 Quanterix Blood Test for Alzheimer's Disease Introduction

11.1.4 Quanterix Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.1.5 Quanterix Recent Development

11.2 C2N Diagnostics

11.2.1 C2N Diagnostics Company Details

11.2.2 C2N Diagnostics Business Overview

11.2.3 C2N Diagnostics Blood Test for Alzheimer's Disease Introduction

11.2.4 C2N Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.2.5 C2N Diagnostics Recent Development

11.3 Sysmex

11.3.1 Sysmex Company Details

11.3.2 Sysmex Business Overview

11.3.3 Sysmex Blood Test for Alzheimer's Disease Introduction

11.3.4 Sysmex Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.3.5 Sysmex Recent Development

11.4 Quest Diagnostics

11.4.1 Quest Diagnostics Company Details

11.4.2 Quest Diagnostics Business Overview

11.4.3 Quest Diagnostics Blood Test for Alzheimer's Disease Introduction

11.4.4 Quest Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.4.5 Quest Diagnostics Recent Development

11.5 Roche Diagnostics

11.5.1 Roche Diagnostics Company Details

11.5.2 Roche Diagnostics Business Overview

11.5.3 Roche Diagnostics Blood Test for Alzheimer's Disease Introduction

11.5.4 Roche Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.5.5 Roche Diagnostics Recent Development

11.6 Fujirebio

11.6.1 Fujirebio Company Details

11.6.2 Fujirebio Business Overview

11.6.3 Fujirebio Blood Test for Alzheimer's Disease Introduction

11.6.4 Fujirebio Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.6.5 Fujirebio Recent Development

11.7 Labcorp

11.7.1 Labcorp Company Details

11.7.2 Labcorp Business Overview

11.7.3 Labcorp Blood Test for Alzheimer's Disease Introduction

11.7.4 Labcorp Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.7.5 Labcorp Recent Development

11.8 Cognitact

11.8.1 Cognitact Company Details

11.8.2 Cognitact Business Overview

11.8.3 Cognitact Blood Test for Alzheimer's Disease Introduction

11.8.4 Cognitact Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.8.5 Cognitact Recent Development

11.9 Amoneta Diagnostics

11.9.1 Amoneta Diagnostics Company Details

11.9.2 Amoneta Diagnostics Business Overview

11.9.3 Amoneta Diagnostics Blood Test for Alzheimer's Disease Introduction

11.9.4 Amoneta Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.9.5 Amoneta Diagnostics Recent Development

11.10 MagQu

11.10.1 MagQu Company Details

11.10.2 MagQu Business Overview

11.10.3 MagQu Blood Test for Alzheimer's Disease Introduction

11.10.4 MagQu Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.10.5 MagQu Recent Development

11.11 Diadem

11.11.1 Diadem Company Details

11.11.2 Diadem Business Overview

11.11.3 Diadem Blood Test for Alzheimer's Disease Introduction

11.11.4 Diadem Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.11.5 Diadem Recent Development

11.12 Vazyme

11.12.1 Vazyme Company Details

11.12.2 Vazyme Business Overview

11.12.3 Vazyme Blood Test for Alzheimer's Disease Introduction

11.12.4 Vazyme Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.12.5 Vazyme Recent Development

11.13 KingMed Diagnostics

11.13.1 KingMed Diagnostics Company Details

11.13.2 KingMed Diagnostics Business Overview

11.13.3 KingMed Diagnostics Blood Test for Alzheimer's Disease Introduction

11.13.4 KingMed Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.13.5 KingMed Diagnostics Recent Development

11.14 DIAN Diagnostics

11.14.1 DIAN Diagnostics Company Details

11.14.2 DIAN Diagnostics Business Overview

11.14.3 DIAN Diagnostics Blood Test for Alzheimer's Disease Introduction

11.14.4 DIAN Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.14.5 DIAN Diagnostics Recent Development

11.15 Anqun Bioengineering

11.15.1 Anqun Bioengineering Company Details

11.15.2 Anqun Bioengineering Business Overview

11.15.3 Anqun Bioengineering Blood Test for Alzheimer's Disease Introduction

11.15.4 Anqun Bioengineering Revenue in Blood Test for Alzheimer's Disease Business (2020-2025)

11.15.5 Anqun Bioengineering Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Blood Test for Alzheimer's Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Amyloid Beta (Aβ)

Table 3. Key Players of Tau Proteins

Table 4. Key Players of Others

Table 5. Global Blood Test for Alzheimer's Disease Market Size Growth Rate by Analytical Technology (US$ Million): 2020 VS 2024 VS 2031

Table 6. Key Players of Immunoassay-based Tests

Table 7. Key Players of Mass Spectrometry-based Tests

Table 8. Key Players of Others

Table 9. Global Blood Test for Alzheimer's Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Blood Test for Alzheimer's Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Blood Test for Alzheimer's Disease Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Blood Test for Alzheimer's Disease Market Share by Region (2020-2025)

Table 13. Global Blood Test for Alzheimer's Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Blood Test for Alzheimer's Disease Market Share by Region (2026-2031)

Table 15. Blood Test for Alzheimer's Disease Market Trends

Table 16. Blood Test for Alzheimer's Disease Market Drivers

Table 17. Blood Test for Alzheimer's Disease Market Challenges

Table 18. Blood Test for Alzheimer's Disease Market Restraints

Table 19. Global Blood Test for Alzheimer's Disease Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Blood Test for Alzheimer's Disease Market Share by Players (2020-2025)

Table 21. Global Top Blood Test for Alzheimer's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Test for Alzheimer's Disease as of 2024)

Table 22. Ranking of Global Top Blood Test for Alzheimer's Disease Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Blood Test for Alzheimer's Disease Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Blood Test for Alzheimer's Disease, Headquarters and Area Served

Table 25. Global Key Players of Blood Test for Alzheimer's Disease, Product and Application

Table 26. Global Key Players of Blood Test for Alzheimer's Disease, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Blood Test for Alzheimer's Disease Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Blood Test for Alzheimer's Disease Revenue Market Share by Type (2020-2025)

Table 30. Global Blood Test for Alzheimer's Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Blood Test for Alzheimer's Disease Revenue Market Share by Type (2026-2031)

Table 32. Global Blood Test for Alzheimer's Disease Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Blood Test for Alzheimer's Disease Revenue Market Share by Application (2020-2025)

Table 34. Global Blood Test for Alzheimer's Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Blood Test for Alzheimer's Disease Revenue Market Share by Application (2026-2031)

Table 36. North America Blood Test for Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Blood Test for Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Blood Test for Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Blood Test for Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Blood Test for Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Blood Test for Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Blood Test for Alzheimer's Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Blood Test for Alzheimer's Disease Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Blood Test for Alzheimer's Disease Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Blood Test for Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Blood Test for Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Blood Test for Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Blood Test for Alzheimer's Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Blood Test for Alzheimer's Disease Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Blood Test for Alzheimer's Disease Market Size by Country (2026-2031) & (US$ Million)

Table 51. Quanterix Company Details

Table 52. Quanterix Business Overview

Table 53. Quanterix Blood Test for Alzheimer's Disease Product

Table 54. Quanterix Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 55. Quanterix Recent Development

Table 56. C2N Diagnostics Company Details

Table 57. C2N Diagnostics Business Overview

Table 58. C2N Diagnostics Blood Test for Alzheimer's Disease Product

Table 59. C2N Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 60. C2N Diagnostics Recent Development

Table 61. Sysmex Company Details

Table 62. Sysmex Business Overview

Table 63. Sysmex Blood Test for Alzheimer's Disease Product

Table 64. Sysmex Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 65. Sysmex Recent Development

Table 66. Quest Diagnostics Company Details

Table 67. Quest Diagnostics Business Overview

Table 68. Quest Diagnostics Blood Test for Alzheimer's Disease Product

Table 69. Quest Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 70. Quest Diagnostics Recent Development

Table 71. Roche Diagnostics Company Details

Table 72. Roche Diagnostics Business Overview

Table 73. Roche Diagnostics Blood Test for Alzheimer's Disease Product

Table 74. Roche Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 75. Roche Diagnostics Recent Development

Table 76. Fujirebio Company Details

Table 77. Fujirebio Business Overview

Table 78. Fujirebio Blood Test for Alzheimer's Disease Product

Table 79. Fujirebio Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 80. Fujirebio Recent Development

Table 81. Labcorp Company Details

Table 82. Labcorp Business Overview

Table 83. Labcorp Blood Test for Alzheimer's Disease Product

Table 84. Labcorp Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 85. Labcorp Recent Development

Table 86. Cognitact Company Details

Table 87. Cognitact Business Overview

Table 88. Cognitact Blood Test for Alzheimer's Disease Product

Table 89. Cognitact Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 90. Cognitact Recent Development

Table 91. Amoneta Diagnostics Company Details

Table 92. Amoneta Diagnostics Business Overview

Table 93. Amoneta Diagnostics Blood Test for Alzheimer's Disease Product

Table 94. Amoneta Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 95. Amoneta Diagnostics Recent Development

Table 96. MagQu Company Details

Table 97. MagQu Business Overview

Table 98. MagQu Blood Test for Alzheimer's Disease Product

Table 99. MagQu Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 100. MagQu Recent Development

Table 101. Diadem Company Details

Table 102. Diadem Business Overview

Table 103. Diadem Blood Test for Alzheimer's Disease Product

Table 104. Diadem Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 105. Diadem Recent Development

Table 106. Vazyme Company Details

Table 107. Vazyme Business Overview

Table 108. Vazyme Blood Test for Alzheimer's Disease Product

Table 109. Vazyme Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 110. Vazyme Recent Development

Table 111. KingMed Diagnostics Company Details

Table 112. KingMed Diagnostics Business Overview

Table 113. KingMed Diagnostics Blood Test for Alzheimer's Disease Product

Table 114. KingMed Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 115. KingMed Diagnostics Recent Development

Table 116. DIAN Diagnostics Company Details

Table 117. DIAN Diagnostics Business Overview

Table 118. DIAN Diagnostics Blood Test for Alzheimer's Disease Product

Table 119. DIAN Diagnostics Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 120. DIAN Diagnostics Recent Development

Table 121. Anqun Bioengineering Company Details

Table 122. Anqun Bioengineering Business Overview

Table 123. Anqun Bioengineering Blood Test for Alzheimer's Disease Product

Table 124. Anqun Bioengineering Revenue in Blood Test for Alzheimer's Disease Business (2020-2025) & (US$ Million)

Table 125. Anqun Bioengineering Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. Blood Test for Alzheimer's Disease Picture

Figure 2. Global Blood Test for Alzheimer's Disease Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Blood Test for Alzheimer's Disease Market Share by Type: 2024 VS 2031

Figure 4. Amyloid Beta (Aβ) Features

Figure 5. Tau Proteins Features

Figure 6. Others Features

Figure 7. Global Blood Test for Alzheimer's Disease Market Size Comparison by Analytical Technology (2020-2031) & (US$ Million)

Figure 8. Immunoassay-based Tests Features

Figure 9. Mass Spectrometry-based Tests Features

Figure 10. Others Features

Figure 11. Global Blood Test for Alzheimer's Disease Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Blood Test for Alzheimer's Disease Market Share by Application: 2024 VS 2031

Figure 13. Early Diagnosis Case Studies

Figure 14. Clinical Research Case Studies

Figure 15. Blood Test for Alzheimer's Disease Report Years Considered

Figure 16. Global Blood Test for Alzheimer's Disease Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Blood Test for Alzheimer's Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Blood Test for Alzheimer's Disease Market Share by Region: 2024 VS 2031

Figure 19. Global Blood Test for Alzheimer's Disease Market Share by Players in 2024

Figure 20. Global Blood Test for Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Blood Test for Alzheimer's Disease Revenue in 2024

Figure 22. North America Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Blood Test for Alzheimer's Disease Market Share by Country (2020-2031)

Figure 24. United States Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Blood Test for Alzheimer's Disease Market Share by Country (2020-2031)

Figure 28. Germany Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Ireland Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Blood Test for Alzheimer's Disease Market Share by Region (2020-2031)

Figure 36. China Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia & New Zealand Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Blood Test for Alzheimer's Disease Market Share by Country (2020-2031)

Figure 44. Mexico Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Blood Test for Alzheimer's Disease Market Share by Country (2020-2031)

Figure 48. Israel Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Blood Test for Alzheimer's Disease Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Quanterix Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 52. C2N Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 53. Sysmex Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 54. Quest Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 55. Roche Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 56. Fujirebio Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 57. Labcorp Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 58. Cognitact Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 59. Amoneta Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 60. MagQu Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 61. Diadem Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 62. Vazyme Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 63. KingMed Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 64. DIAN Diagnostics Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 65. Anqun Bioengineering Revenue Growth Rate in Blood Test for Alzheimer's Disease Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions